Endpoints News 6 janv. 2026 Arrowhead’s RNAi obesity programs head to Phase 2 after encouraging early data
Endpoints News 5 janv. 2026 FDA raises new questions with Sanofi's MS drug in release of rejection letter
Endpoints News 5 janv. 2026 HHS urges Supreme Court to decline AstraZeneca's petition over Medicare price negotiations
Endpoints News 5 janv. 2026 US to stop recommending six vaccines for all kids, prioritizing individual choice and higher-risk groups
Endpoints News 5 janv. 2026 Crinetics reports robust full-quarter sales for rare disease drug Palsonify
Endpoints News 5 janv. 2026 Aktis Oncology eyes $181M listing to start industry’s anticipated IPO rebound
Endpoints News 5 janv. 2026 Novo Nordisk launches Wegovy pill at $25 per month for insured patients, $149 cash